After a slow Thanksgiving week, investors made up for lost time with a slew of big-money rounds. VCs spread their cash around ...

Nuvig Therapeutics raises $161 million in Series B funding to advance novel immunomodulatory treatments for autoimmune ...

Nuvig Therapeutics has closed a $161m Series B financing round to advance its preclinical pipeline and support NVG-2089’s ...

Investment group Atlas Ventures has closed its fourteenth fund, raising $450 million for the next round of investment in ...

California-based biotech Nuvig Therapeutics scooped up $161 million from the investment arms of Sanofi, Bayer, Novo Holdings, ...

The company is developing treatments to rebalance, rather than suppress, immune function in people with inflammatory ...

Precision Diagnostics, a leader in innovative diagnostic solutions, announces the launch of VerifID, a groundbreaking solution that redefines sample ...

Foundation Medicine, Inc. today announced it has awarded two grants to organizations working to address disparities in biomarker testing for breast and prostate cancer following its open call for ...

Nuvig Therapeutics Announces $161 Million Series B Financing and Progression to Phase 2 Development with Novel, ...

An immunomodulatory startup called Nuvig Therapeutics announced a $161 million Series B amid rising competition to develop ...

Big Pharma-backed immunomodulation biotech Nuvig Therapeutics is moving its lead asset into phase 2 trials using a $161 ...

The Food and Drug Administration has approved a new medicine for a deadly genetic heart condition, boosting its developer, BridgeBio Pharma, and teeing up a battle for control of a lucrative market ...